IOZK Veröffentlichungen Archive - Seite 2 von 11 - IOZK

Synergy between TMZ and individualized multimodal immunotherapy to improve overall survival of IDH1 wild-type MGMT promoter-unmethylated GBM patients

2022-02-16/in Dendritic Cells, Glioblastoma, Hyperthermia, International Publications, IOZK Veröffentlichungen, Newcastle Disease Virus /von 2022-02-16 / Genes Immun 2022 Feb;

Stem cells-derived natural killer cells for cancer immunotherapy: current protocols, feasibility, and benefits of ex vivo generated natural killer cells in treatment of advanced solid tumors

2021-07-04/in International Publications, IOZK Veröffentlichungen /von 2021-07-04 / Cancer Immunol Immunother 2021 Jul;

DNA methylation based glioblastoma subclassification is related to tumoral T-cell infiltration and patient survival

2021-02-25/in Glioblastoma, International Publications, IOZK Veröffentlichungen /von 2021-02-25 / Neuro Oncol 2021 02;23(2):240-250

Impaired DNA repair in mouse monocytes compared to macrophages and precursors

2020-12-30/in International Publications, IOZK Veröffentlichungen /von 2020-12-30 / DNA Repair (Amst) 2020 Dec;98:103037

Randomized Controlled Immunotherapy Clinical Trials for GBM Challenged

2020-12-24/in Dendritic Cells, Glioblastoma, Hyperthermia, International Publications, IOZK Veröffentlichungen, Newcastle Disease Virus /von 2020-12-24 / Cancers (Basel) 2020 Dec;13(1)

Mitochondria at Work: New Insights into Regulation and Dysregulation of Cellular Energy Supply and Metabolism

2020-11-22/in International Publications, IOZK Veröffentlichungen /von 2020-11-22 / Biomedicines 2020 Nov;8(11)

Evidence-Based Medicine in Oncology: Commercial Versus Patient Benefit

2020-07-23/in International Publications, IOZK Veröffentlichungen /von 2020-07-23 / Biomedicines 2020 Jul;8(8)

Position paper: new insights into the immunobiology and dynamics of tumor-host interactions require adaptations of clinical studies

2020-06-30/in Dendritic Cells, Glioblastoma, Hyperthermia, International Publications, IOZK Veröffentlichungen, Newcastle Disease Virus /von 2020-06-30 / Expert Rev Anticancer Ther 2020 Aug;20(8):639-646

IOZK Analyse belegt gute Verträglichkeit der IOZK Immuntherapie beim Diffusen intrinsischen pontinen Gliom (DIPG)

2020-06-02/in IOZK Veröffentlichungen /von IOZK

Addition of Multimodal Immunotherapy to Combination Treatment Strategies for Children with DIPG: A Single Institution Experience

2020-05-19/in Brain Tumors in Children, Dendritic Cells, Hyperthermia, International Publications, IOZK Veröffentlichungen, Newcastle Disease Virus /von 2020-05-19 / Medicines (Basel) 2020 May;7(5)